Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

TxDOT Opts Balfour Beatty JV Team As Bidder For Dallas Horseshoe Project

Balfour Beatty Plc (BBY.L) said it has been named as best value bidder, as part of a design-build joint venture with Fluor Corp., to undertake the upgrades and replacements of river crossings in Dallas, Texas. The Texas Department of Transportation's, or TxDOT, estimate for the design, construction, utilities and right of way for the project is around $798 million, or 502 million pounds.

The 'Dallas Horseshoe' project calls for the upgrade and replacement of the I-30 and I-35E bridges and construction of additional lanes as well as the previously designed Margaret McDermott bridges. TxDOT will utilise design-build project delivery to shorten the construction schedule and lower the overall cost. The design work will start in early 2013 and construction will be completed in 2017.

Click here to receive FREE breaking news email alerts for Balfour Beatty Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks continue to show a lack of direction in mid-day trading on Tuesday following the long, holiday weekend. Even with the lackluster performance, the markets are largely holding on to the bulk of their recent gains. After reporting an unexpected drop in U.S. construction spending in the previous month, the Commerce Department released a report on Tuesday showing that construction spending rebounded by more than expected in the month of July. Activity in the U.S. manufacturing sector unexpectedly grew at an accelerated rate in the month of August, according to a report released by the Institute for Supply Management on Tuesday, with the index of activity in the sector climbing to a three-year high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.